Dr. Barry Dworkin

Targeted chemotherapy for HER2 breast cancer patients shows good results in phase 3 study

Madely Health Headlines Commentary for October 3, 2012

Source:

Breast cancer treatment targets tumours with few side effects

Reference:

Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

Related posts:

  1. Genentech asking FDA for accelerated approval for drug to treat early-stage HER-2 breast cancer
  2. More genes linked to breast cancer risk
  3. More information needed about woman's breast cancer before slamming Ontario Government for not covering breast-cancer drug
  4. New class of prostate cancer drug treatment to start clinical trials